Warrior Mist

VISUAL OCUITY

Soothing Lubricant Eye Drops with Carnosine

1% N-Acetyl-Carnosine

Antiglycating Formula Supports Healthy Eye Function and Superior Vision


VISUAL OCUITY $35.95

You might also like:

Visual Ocuity


As Recommended by Dr. Julian Whitaker in “Restore Fading Eyesight Forever” and Health & Healing, and Dr. David Williams’ Alternatives!

VISUAL OCUITY is an eye drop formula containing as active ingredients the lubricants glycerin (1.0%) and hydroxypropylmethylcellulose (0.3%). VISUAL OCUITY also contains sterile water (opthalmic grade isotonic solution, pH 6.3 to 6.5), N-Acetyl-L-Carnosine (NAC) (1.0%), buffering agents (boric acid, citric acid, and potassium bicarbonate), and purified benzyl alcohol as a preservative. One box contains two (2) large vials (5.0 ml each) of the eye drop solution.


CONSIDERATIONS AND APPLICATIONS

VISUAL OCUITY has been designed to support healthy eye function. A wide range of causes including excessive free radicals, smoke, dust, ultraviolet rays, excessive sugars, drug use, inadequate nutrient levels, and poor blood flow can lead to conditions such as cataracts, glaucoma, retinal/macular degeneration, corneal disorders, ocular inflammation, and complications of Diabetes Mellitus. An eye drop formula containing lubricants and antiglycating agents can help to prevent or reverse many of these conditions. Research studies on NAC are discussed below.

N-ACETYL-L-CARNOSINE (NAC)

N-Acetyl-L-Carnosine (NAC) is a timed release form of the naturally occurring dipeptide L-carnosine—a powerful antioxidant and antiglycating agent. Both in human and animal studies NAC shows remarkable effects in protecting and healing the eyes.

N-Acetyl-L-Carnosine (a natural combination of beta-alanine and L-histidine) acts both as a powerful antioxidant and as an inhibitor of glycation. Glycation results when sugars (e.g., glucose) react with proteins, creating damaging substances known as ‘Advanced Glycation End Products’ (AGEs). This is a process of cross-linking that is characteristic of biological aging.

Dr. Linus Pauling has shown how dietary sugars (especially sucrose) play a prominent role in collagen cross-linking throughout the human body, and that sugars target collagen structures more specifically. High-collagen structures include skin, connective tissues (e.g., ligaments, tendons, and bones), and the cornea and lens of the eye (in crystalline form). He likens the cross-linking process to the tanning of hide, whereby formerly flexible, soft tissues become hard and leathery (and lose their proper internal structure and tensile strength). (See Dr. Pauling’s How To Live Longer and Feel Better, rept. 2006.)

Other scientists and researchers liken specifically the formation of cataracts to the clouding of egg white during pan frying, as the proteins in the albumen become glycated during the cooking process. In living organisms including humans, such ‘tanning’ or ‘clouding’ represents an interference (i.e., a fundamental loss) in the structure and function of the organs and/or tissues involved in the glycation process.

While glycation and creation of AGEs are considered perfectly ‘normal’ in aging, these processes may become accelerated by free radicals in the environment (e.g., oxidant chemicals), as well as by dietary factors (endogenous and exogenous). Conversely, factors such an increased intake of antioxidants or reduction of substances (e.g., sugars) that participate in cross-linking of collagen fibers can help reduce rates of glycation and generation of AGEs.

Dr. Pauling, for example, shows that high levels of vitamin C protect collagen fibers during exposure to glycating agents, not only because of elevated antioxidant activity in vivo (i.e., increased free-radical quenching capacity in the body) but also because Vitamin C is needed for collagen formation and synthesis—one of the primary reasons Dr. Pauling emphasizes Vitamin C in his nutritional supplement regimens.

This means Vitamin C directy counteracts the glycating action of sugars on collagen tissues, hindering the accelerated aging that might otherwise occur as a result of glycation. Vitamin C is thereby a prime example of a natural substance that protects proteins from glycation (and demonstrates the effectiveness of what Dr. Pauling terms ‘orthomolecular’ medicine).

While L-Carnosine utilizes a different mode of action than Vitamin C, and is unique in its capacity as a topical antiglycating agent, it is likewise a natural substance that works with the body to serve its healing and repair processes.

Science understands therefore that it is largely because the human body is built of proteins (e.g., collagen) that any substances (whether food substances, chemicals, environmental oxidants, etc.) that induce glycation (and deterioration of proteins) can result in harmful effects to our biological systems, including accelerated aging, and processes leading to degenerative disease and decreased lifespan. This biochemical model affirms the free-radical theory of aging.

The scientific establishment’s acceptance of the free-radical theory of aging in turn suggests that for increased health it is beneficial to maximize extant antioxidant systems in the body (e.g., via supplying proper nutrition) and to use current knowledge regarding, for example, oxidation and glycation processes to build health and retard accelerated aging using natural antioxidants and glycation inhibitors that are most easily recognized by the body.

Recent studies indicate that N-Acetyl-L-Carnosine (NAC) is an extremely effective antiglycating agent. The L-carnosine molecule effectively competes with proteins for binding sites on sugar molecules, consequently thwarting glycation and subsequent damage to proteins. Research also suggests that L-carnosine binds to and modifies existing AGEs supporting the body’s efforts to remove deleterious or toxic glycation end products.

Glycation occurs in the human eye when the protein dense lens reacts chemically with various sugars. One result of this glycation process can be clouding of the lens, or cataract formations. Topical N-Acetyl-L-Carnosine (NAC) has been shown to be a potent antiglycating agent that supports the eyes by helping to counteract or reverse the advancement of existing glycations, and has proven to be useful and effective in protocols for preventing the formation of new glycations.


CLINICAL STUDIES DEMONSTRATE EFFECTIVENESS

According to Dr. Mark Babizhayev, a leading NAC researcher:

“The NAC anti-cataract eye drops have been carefully tested in animals. We have processed the treatment of age-related cataracts in canines and experimental models of cataract in rabbits. The most striking results have been obtained using a 1% NAC instillation in canines with age-related cataracts. We have determined the efficacy of cataract treatment, and we have revealed a new phenomenon of melting snow upon the instillation of NAC, for the chronic treatment of cataract within only one month. The cortical appearance of cataract reversal starts from the periphery and then the lens becomes more transparent. This is then accompanied by the improved visual behavior of the animal. Rigorous computerized image analysis have been supplied to support the evidence of the cataract treatment in rabbits. The striking results of reversing cataract and the prevention of the lens opacities are clear….” In a clinical study of older people with early diagnosis of senile cataracts Dr. Babizhayev states:

“We developed sensitive measurements for the lens opacities in humans. These were original techniques of glare tests; they are very sensitive to even tiny changes of the lens opacities and we also tested the macular function, which is the vision behind the cataract...One group of patients were the control reference group, they demonstrated the variability in densitometric readings of lens clouding and they had negative advance in glare sensitivity at 6 months, and a gradual deterioration of visual acuity and gross transmissivity of lenses at 24 months...However, when compared with baseline examination at 6 months, 41.5% of the eyes treated with NAC eye drops presented a significant improvement in visual acuity of 7–100% and 88.9% of the eyes ranged a 27–100% improvement in glare sensitivity. Topographic study demonstrated less density and corresponding areas of opacification in posterior subcapsular and cortical morphological regions of the lens. That is consistent with visual acuity up to 0.3. The total study period was over 24 months and it revealed that the beneficial effect of NAC is sustainable. Image analytical readings of lenses indicated that no cases resulted in a worsening of visual acuity for the NAC-treated group of patients...Statistical analysis revealed significant differences between 6 and 24 months as an overall cumulative and positive change of the characteristics of cataracts in the NAC-treated group, when compared to the control group.”

In addition, a 1999 Chinese study done by A.M. Wang used 96 patients aged 60 years or older having senile cataracts of various degrees of maturity with the duration of the disease from 2 to 21 years. Patients instilled 1–2 drops of the carnosine-containing solution in each eye 3–4 times per day for a period of treatment ranging from 3–6 months. The level of eyesight improvement and the change of lens transparency were considered as an evaluation index of the curative effect of carnosine. The result showed that carnosine gives a pronounced effect on primary senile cataracts, the effective rate being 100%. For mature senile cataracts the effect rate was 80%.

INGREDIENTS: VISUAL OCUITY
 only contains the highest-quality ingredients. Active: Glycerin (lubricant) 1.0%, hydroxypropylmethylcellulose (lubricant) 0.3%. Inactive: Sterile water (opthalmic grade isotonic solution, pH 6.3 to 6.5, N-Acetyl-Carnosine (NAC) 1.0%, buffering agents (boric acid, citric acid, potassium bicarbonate), and purified benzyl alcohol (preservative).

DIRECTIONS: Place 1 or 2 drops in each eye 1–4 times per day, or use as directed by a health care professional. Please carefully read the enclosed product insert. For the proper installation of drops, lean head back and look up. Do not blink or reopen the eye for 60 seconds. If a second drop is used, repeat this process. Closing the eye allows each drop to be absorbed into the eye tissue. Blinking, even one or two times, will pump most of the solution out of the eye. If you have neck problems, lie down or use a tilt-back chair.

 

As Recommended by Dr. Julian Whitaker in “Restore Fading Eyesight Forever” and Health & Healing, and Dr. David Williams’ Alternatives!

Try Visual Ocuity...For Your Best Vision and Healthy Eyes!

 

LETTERS FROM VERY SATISFIED CUSTOMERS

October 14, 2006

Dear Health Products Distributors, Inc.,

I want to thank you and tell you how grateful I am for Visual Ocuity. I was so afraid to have cataract surgery. I read about these eye drops, ordered them and within two weeks my vision was better. In two months I quit wearing my glasses (I am 79 years old and have worn glasses since I was 17). I am so excited to see well—colors are clearer and brighter. Thank you for giving me clear vision and no cataracts! Thank you!

— Ester Fox, Muskogee, OK


May 8, 2007

I started using Visual Ocuity in November 2006. I had cataracts in both eyes and very dry eyes. After using Visual Ocuity for 6 months my cataracts are almost gone, my pressure has dropped 1 point, and my eyes aren’t nearly as dry. I’m so glad I started using the drops!! Thank you,

— Janfer D. Reeves, Weldon, IL


June 28, 2007

Dear HPDI,

I really like this product. I am now able to drive confidently again, with my better vision.

— Margaret Younk, Harrisville, MI


December 29, 2007

This formula actually works!! Simply astounding!!!! Thank you!

— Linda Langsjoen, Minneapolis, MN


March 28, 2008

My cataracts had been so large the retinal specialist could not see the blood vessels in my eyes. After six months of using Visual Ocuity, I visited my optometrist, who was surprised to see I no longer had cataracts! I have been using Visual Ocuity for two years, and I remain cataract free.

— Philip MacBain, age 84, Marina, CA


April 11, 2008

The eye solution is slowly reversing my dry eye problem. Love it!

— Jennifer Luther, Coronado, CA


June 3, 2008

I am delighted with the results I am getting with Visual Ocuity. I started using it for my cataracts in mid-February. The cloud began to dissolve in April. Now my cloudy vision is gone and I am beginning to see clearly!

— Geraldine Baker, age 79, Young Harris, GA

 

 

These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.